Clinico-microbiological study and antimicrobial drug resistance profile of diabetic foot infections in North India.

The study was carried out in diabetic patients with foot ulcer to determine the microbiological profile of infected ulcer, antibiotic resistance of the isolates and to find out the potential risk factors for infection with multidrug resistance and the outcome of these infections. A detailed clinical history and physical examination was carried out in each patient. Pus samples for bacterial culture were collected from 102 patients admitted with diabetic foot infections. All patients had ulcer with Texas grades 1-3. Seventeen patients (16.6%) had coexisting osteomyelitis. Aerobic gram negative bacilli were tested for extended spectrum β lactamase (ESBL) production by phenotypic and genotypic methods. Staphylococcus isolates were tested for susceptibility to oxacillin and cefoxitin by disk method. Potential risk factors for MDRO positive samples were explored. Gram negative aerobes were most frequently isolated (63.8%), followed by gram positive aerobes (36.1%) and anaerobes (31.4%). Forty five percent of patients were positive for MDROs. ESBL production and methicillin resistant was noted in 68.5% and 43.2% of bacterial isolates respectively. 34.5% gram negative strains were positive for bla(CTX-M) gene followed by bla(SHV) (23%) and bla(TEM) (7.4%). Among the anaerobic organism 17(31.4%) from 54 patients, most commonly isolated were Peptostreptococcus sp. (35.2%). MDRO positive status was associated with the presence of neuropathy (P<0.001), osteomyelitis (P<0.03), and ulcer size >4 cm(2) (P<0.01) [corrected] but not with patients characteristic, ulcer type and type of diabetes, or duration of hospital stay. Poor glycemic control in 68.6% patients, duration of infection>1 month (36.2%) and ulcer size >4 cm(2) (75.4%) were independently associated with risk of MDR organisms infection.

[1]  V. Jarlier,et al.  Diabetic foot ulcer and multidrug‐resistant organisms: risk factors and impact , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[2]  V. Mohan,et al.  Bacterial etiology of diabetic foot infections in South India. , 2005, European journal of internal medicine.

[3]  Ambady Ramachandran,et al.  Prevalence of pathogens in diabetic foot infection in South Indian type 2 diabetic patients. , 2002, The Journal of the Association of Physicians of India.

[4]  K. Itani,et al.  Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  A. Boulton,et al.  Methicillin‐resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[6]  T. Yoshikawa,et al.  Infections in diabetes. , 2001, Infectious disease clinics of North America.

[7]  S. Kaplan,et al.  Foot infections in diabetic patients. Decision and cost-effectiveness analyses. , 1995, JAMA.

[8]  Benjamin A Lipsky,et al.  Outpatient management of uncomplicated lower-extremity infections in diabetic patients. , 1990, Archives of internal medicine.

[9]  V. Ensor,et al.  Emergence and dissemination of Enterobacteriaceae with plasmid-mediated CMY-6 and CTX-M-15 beta-lactamases in community in North-India , 2009 .

[10]  B. Murray New aspects of antimicrobial resistance and the resulting therapeutic dilemmas. , 1991, The Journal of infectious diseases.

[11]  A. T. Willis Clostridia of Wound Infection , 1969 .

[12]  Marley Ds Decision and cost-effectiveness analysis. , 1990 .

[13]  K. Scher,et al.  The septic foot in patients with diabetes. , 1988, Surgery.

[14]  M. Toleman,et al.  Comment on: Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals. , 2007, The Journal of antimicrobial chemotherapy.

[15]  V. Ensor,et al.  Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals. , 2006, The Journal of antimicrobial chemotherapy.

[16]  N. Raja,et al.  Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective study of 194 cases. , 2007, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[17]  D. Armstrong,et al.  Advances in the treatment of diabetic foot infections. , 2004, Diabetes technology & therapeutics.

[18]  Benjamin A Lipsky,et al.  Principles and practice of antibiotic therapy of diabetic foot infections , 2000, Diabetes/metabolism research and reviews.

[19]  O. Kassim,et al.  Characterization of bacterial isolates from diabetic foot infections in Ile-Ife, Southwestern Nigeria , 2006 .

[20]  N. Schaper,et al.  The effect of diabetes and severe ischaemia on the penetration of ceftazidime into tissues of the limb , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[21]  R. Moellering,et al.  Antimicrobial-drug resistance. , 1996, The New England journal of medicine.

[22]  K. Kapila,et al.  Comparison of cefoxitin disc diffusion test, oxacillin screen agar, and PCR for mecA gene for detection of MRSA. , 2009, Indian journal of medical microbiology.

[23]  E. Goldstein,et al.  Diabetic Foot Infections: Bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases , 1996, Diabetes Care.

[24]  D. Armstrong,et al.  Who is at risk for diabetic foot ulceration? , 1998, Clinics in podiatric medicine and surgery.

[25]  P. M. L. Quesne,et al.  Impaired neurogenic vascular response in patients with diabetes and neuropathic foot lesions. , 1988, The New England journal of medicine.

[26]  A. Boulton,et al.  CHAPTER 24 – DIABETIC FOOT PROBLEMS AND THEIR MANAGEMENT AROUND THE WORLD , 2008 .

[27]  B. Wiedemann Plasmid-mediated extended spectrum beta-lactamases* , 1992 .

[28]  W. F. Todd,et al.  1995 William J. Stickel Bronze Award. Prevalence of mixed infections in the diabetic pedal wound. A retrospective review of 112 infections. , 1995, Journal of the American Podiatric Medical Association.

[29]  K. Plaisance,et al.  MRSA colonization and the risk of MRSA bacteraemia in hospitalized patients with chronic ulcers. , 2001, The Journal of hospital infection.

[30]  M. Adil,et al.  Comparison of beta-lactamase genes in clinical and food bacterial isolates in India. , 2009, Journal of infection in developing countries.

[31]  Jesse A Berlin,et al.  Diabetic neuropathic foot ulcers: the association of wound size, wound duration, and wound grade on healing. , 2002, Diabetes care.

[32]  A. Boulton,et al.  The diabetic foot. , 2007, Clinics in dermatology.

[33]  Benjamin A Lipsky,et al.  Diagnosis and treatment of diabetic foot infections. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  M. Edmonds,et al.  The use of antibiotics in the diabetic foot. , 2004, American journal of surgery.

[35]  James S. M. Tan Foot Infections in diabetic patients , 2004, Current infectious disease reports.

[36]  J. Bartlett,et al.  Aerobic and Anaerobic Bacteria in Diabetic Foot Ulcers , 1976 .

[37]  H. Khan,et al.  In vitro efficacy of ceftriaxone/sulbactam against Escherichia coli isolates producing CTX-M-15 extended-spectrum beta-lactamase. , 2007, The Journal of antimicrobial chemotherapy.

[38]  Y. Ramot,et al.  Swab cultures accurately identify bacterial pathogens in diabetic foot wounds not involving bone , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[39]  A. Karchmer,et al.  Infections in patients with diabetes mellitus. , 1999, The New England journal of medicine.

[40]  D. Gerding Foot infections in diabetic patients: the role of anaerobes. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  J. E. Mccartney,et al.  Mackie & McCartney practical medical microbiology , 1996 .

[42]  Robert A. Bonomo,et al.  Extended-Spectrum (cid:2) -Lactamases: a Clinical Update , 2005 .

[43]  B. Appalaraju,et al.  Extended spectrum -lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae - prevalence and susceptibility pattern in a tertiary care hospital. , 2004, Indian journal of medical microbiology.